Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276)

64.18+0.40+0.63%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

Company Profile
Company Name
江苏恒瑞医药股份有限公司
Industry
医药制造业
Listing Date
2000-10-18
Registered Capital
663719万元
Introduction
江苏恒瑞医药股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是硫培非格司亭注射液、马来酸吡咯替尼片、注射用卡瑞利珠单抗、瑞维鲁胺片、海曲泊帕乙醇胺片、碘佛醇注射液。

1D
5D
Day
Week
Month

Loading ...

High

64.20

Open

64.10

T/O Rate

0.01%

Low

64.07

63.78

Amplitude

0.20%

Most Discussed

{"pagemeta":{"title":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.,600276,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票老虎,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票老虎国际,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.行情,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票行情,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股价,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股市,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票价格,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票交易,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票购买,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}},"tab":"summary","symbol":"600276","data":{"stockData":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.","latestPrice":64.18,"timestamp":1768181427000,"preClose":63.78,"halted":0,"volume":508016,"delay":0,"changeRate":0.0063,"floatShares":6379000000,"shares":6637000000,"eps":1.1252,"marketStatus":"Trading","change":0.4,"latestTime":"01-12 09:30:27","open":64.1,"high":64.2,"low":64.07,"amount":32576500,"amplitude":0.002,"askPrice":64.18,"askSize":92,"bidPrice":64.15,"bidSize":31,"shortable":0,"etf":0,"ttmEps":1.1252,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1768188600000},"marketStatusCode":2,"adr":0,"adjPreClose":63.78,"symbolType":"stock","openAndCloseTimeList":[[1768181400000,1768188600000],[1768194000000,1768201200000]],"highLimit":70.16,"lowLimit":57.4,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":6637199874,"isCdr":false,"pbRate":7.11,"roa":"--","peRate":57.038749,"roe":"11.09%","epsLYR":1,"committee":0.67259,"marketValue":425975000000,"turnoverRate":0.0001,"status":0,"hkstockBrief":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"HENGRUI PHARMA","latestPrice":78.2,"timestamp":1768181428146,"preClose":76.75,"halted":0,"volume":18064,"delay":0,"premium":"+8.92"},"floatMarketCap":409404000000},"tweetData":null,"newsData":null,"noticeData":{"listData":[],"currentPage":1,"bottom":true},"companyData":{"profile":null,"aProfile":{"ret":0,"listingDate":"2000-10-18","address":"江苏省连云港市连云区经济技术开发区黄河路38号","stockEarnings":[{"period":"1week","weight":0.0707},{"period":"1month","weight":0.0063},{"period":"3month","weight":-0.0648},{"period":"6month","weight":0.1209},{"period":"1year","weight":0.4858},{"period":"ytd","weight":0.0707}],"companyName":"江苏恒瑞医药股份有限公司","boardCode":"AI0027","perCapita":"16058股","boardName":"医药制造业","registeredCapital":"663719万元","compareEarnings":[{"period":"1week","weight":0.0382},{"period":"1month","weight":0.0564},{"period":"3month","weight":0.0573},{"period":"6month","weight":0.1739},{"period":"1year","weight":0.2831},{"period":"ytd","weight":0.0382}],"survey":"　　江苏恒瑞医药股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是硫培非格司亭注射液、马来酸吡咯替尼片、注射用卡瑞利珠单抗、瑞维鲁胺片、海曲泊帕乙醇胺片、碘佛醇注射液。","serverTime":1768181429254,"listedPrice":11.98,"stockholders":"397246人(较上一季度增加8.94%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}}}}}

Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276)

Company Profile

Most Discussed